These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23197105)

  • 1. Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis.
    Fonnesbeck CJ; McPheeters ML; Krishnaswami S; Lindegren ML; Reimschisel T
    J Inherit Metab Dis; 2013 Sep; 36(5):757-66. PubMed ID: 23197105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis.
    Waisbren SE; Noel K; Fahrbach K; Cella C; Frame D; Dorenbaum A; Levy H
    Mol Genet Metab; 2007; 92(1-2):63-70. PubMed ID: 17591452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V; Kurzius L; Forbes P; Waisbren S
    Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria.
    Hood A; Grange DK; Christ SE; Steiner R; White DA
    Mol Genet Metab; 2014 Apr; 111(4):445-51. PubMed ID: 24568837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria.
    Viau KS; Wengreen HJ; Ernst SL; Cantor NL; Furtado LV; Longo N
    J Inherit Metab Dis; 2011 Aug; 34(4):963-71. PubMed ID: 21556836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult cognitive outcomes in phenylketonuria: explaining causes of variability beyond average Phe levels.
    Romani C; Manti F; Nardecchia F; Valentini F; Fallarino N; Carducci C; De Leo S; MacDonald A; Palermo L; Leuzzi V
    Orphanet J Rare Dis; 2019 Nov; 14(1):273. PubMed ID: 31779649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels.
    Feldmann R; Och U; Beckmann LS; Weglage J; Rutsch F
    Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM; Huijbregts SC; van Spronsen FJ; Verkerk PH; Sergeant JA; Licht R
    Mol Genet Metab; 2010; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial.
    ten Hoedt AE; de Sonneville LM; Francois B; ter Horst NM; Janssen MC; Rubio-Gozalbo ME; Wijburg FA; Hollak CE; Bosch AM
    J Inherit Metab Dis; 2011 Feb; 34(1):165-71. PubMed ID: 21153445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations.
    Huijbregts SC; de Sonneville LM; Licht R; van Spronsen FJ; Verkerk PH; Sergeant JA
    Neuropsychologia; 2002; 40(1):7-15. PubMed ID: 11595258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B; Bik-Multanowski M
    Acta Biochim Pol; 2017; 64(3):527-531. PubMed ID: 28850634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social-cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU-COBESO study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    J Inherit Metab Dis; 2016 May; 39(3):355-362. PubMed ID: 26914933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.